Menu

Back to Directory

Fatty Liver Disease

Fatty liver disease, marked by excessive fat accumulation in the liver, can stem from alcohol abuse or factors like obesity and insulin resistance, potentially causing liver damage.

Fatty liver disease, also known as hepatic steatosis, is a condition characterized by the buildup of excess fat in the liver cells. While it's normal to have some fat in your liver, too much can lead to inflammation, liver damage, and potentially more serious conditions like cirrhosis or liver failure.

Causes

Fatty liver disease can be broadly categorized into two main types based on its cause:
  • Alcoholic Fatty Liver Disease (AFLD):
    • Excessive alcohol consumption: Alcohol is processed by the liver, and heavy drinking can interfere with the liver's ability to metabolize fats, leading to their accumulation. It is the earliest stage of alcohol-related liver disease.
  • Non-Alcoholic Fatty Liver Disease (NAFLD): This is the most common form of fatty liver disease and occurs in people who drink little to no alcohol. The exact cause is unknown, but it is strongly linked to:
    • Obesity: A major risk factor, as excess body fat can lead to fat accumulation in the liver.
    • Insulin resistance: Often seen in type 2 diabetes and prediabetes, where the body's cells don't respond properly to insulin, leading to high blood sugar and fat accumulation in the liver.
    • High cholesterol and triglycerides: Elevated levels of fats in the blood.
    • Metabolic Syndrome: A cluster of conditions including high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels.
    • Rapid weight loss: Can sometimes lead to fat accumulation in the liver.
    • Certain medications: Such as corticosteroids, tamoxifen, and amiodarone.
    • Genetic factors: Some individuals may be genetically predisposed.

Symptoms

Fatty liver disease often causes no symptoms, especially in its early stages. It may be discovered incidentally during tests for other conditions. When symptoms do occur, they can be vague and non-specific, including:
  • Fatigue and weakness
  • Dull ache or pain in the upper right side of the abdomen (where the liver is located)
  • Unexplained weight loss
  • Loss of appetite
  • Nausea
  • Jaundice (yellowing of the skin and eyes, in more advanced stages)
  • Swelling in the legs and abdomen (edema and ascites, in more advanced stages)
  • Confusion or difficulty concentrating (hepatic encephalopathy, in severe cases)

Diagnosis

Diagnosing fatty liver disease often begins with a suspicion based on risk factors or abnormal liver enzyme levels found during routine blood tests. Further tests are then conducted:
  • Medical history and physical exam: The doctor will ask about your alcohol consumption, diet, medications, and any symptoms. A physical exam may reveal an enlarged liver.
  • Blood tests:
    • Liver function tests (LFTs): Elevated liver enzymes (ALT, AST) can indicate liver inflammation or damage.
    • Blood glucose and A1C: To check for diabetes or insulin resistance.
    • Lipid panel: To check cholesterol and triglyceride levels.
    • Tests for viral hepatitis (A, B, C): To rule out other causes of liver disease.
  • Imaging tests:
    • Ultrasound: Often the first imaging test, it can detect fat in the liver.
    • CT scan (Computed Tomography): Provides more detailed images of the liver.
    • MRI (Magnetic Resonance Imaging): Can accurately quantify fat in the liver and assess for inflammation or fibrosis.
    • Transient Elastography (FibroScan): A specialized ultrasound that measures liver stiffness, which can indicate fibrosis (scarring) or cirrhosis.
  • Liver biopsy: This is considered the gold standard for diagnosing fatty liver disease and assessing the severity of inflammation and fibrosis. A small tissue sample is removed from the liver and examined under a microscope. It helps differentiate between simple fatty liver and non-alcoholic steatohepatitis (NASH), a more aggressive form of NAFLD.

Treatment

There is no specific medication to treat fatty liver disease directly. Treatment focuses on managing the underlying causes and risk factors, which can often reverse the condition or prevent its progression.
  • Lifestyle modifications (cornerstone of treatment):
    • Weight loss: Gradual and sustained weight loss (5-10% of body weight) is highly effective in reducing liver fat and inflammation.
    • Healthy diet: Emphasize fruits, vegetables, whole grains, and lean proteins. Limit saturated and trans fats, refined carbohydrates, and sugary drinks.
    • Regular exercise: Helps with weight loss, improves insulin sensitivity, and can reduce liver fat.
    • Avoid alcohol: Complete abstinence from alcohol is crucial for AFLD. For NAFLD, reducing or eliminating alcohol is also beneficial.
    • Manage underlying conditions: Control diabetes, high cholesterol, and high blood pressure through diet, exercise, and medication as prescribed by your doctor.
  • Medications:
    • Resmetirom (Rezdiffra) became the first FDA-approved medication for NASH with moderate to advanced liver fibrosis in 2024; it is prescribed by a liver specialist alongside diet and exercise. Medications for associated conditions (e.g., diabetes, cholesterol, blood pressure) remain important.
    • Vitamin E: May be prescribed for some individuals with NASH who do not have diabetes.
    • Pioglitazone: A diabetes medication that may improve liver inflammation and fibrosis in some people with NASH.
    • Emerging therapies: Several new drugs are under investigation for NASH.
  • Surgery: In severe cases of NAFLD that progress to cirrhosis and liver failure, a liver transplant may be necessary.
Early diagnosis and aggressive lifestyle changes are critical for managing fatty liver disease and preventing its progression to more severe liver conditions.

Turning Fatty Liver Around

Fatty liver is one of the few chronic conditions that can be fully reversed, and one of the most often ignored. What matters after the diagnosis is how much scarring is already present, and a plan that treats the cause rather than the liver.

The question that decides everything is fibrosis

Fat alone rarely harms the liver; scarring does. A simple score calculated from age, routine liver enzymes, and platelet count sorts most people into low risk, who need lifestyle change and a recheck every few years, and higher risk, who need a FibroScan or specialist review. Anyone with type 2 diabetes or several features of metabolic syndrome should have that score run even when liver enzymes are normal, because normal enzymes do not exclude advanced disease. The condition has been renamed metabolic dysfunction-associated steatotic liver disease, or MASLD, which our silent fatty liver article explains.

How much weight, and by what means

Losing roughly a twentieth of body weight clears fat from the liver, losing about a tenth settles inflammation and can begin to reverse scarring. In people with obesity, semaglutide or liraglutide produces that degree of loss for most who stay on it, and resmetirom, the first drug approved specifically for fatty liver with scarring, is an option for selected patients through a liver specialist. Pioglitazone and vitamin E remain choices for the right person.

Statins are safe, and alcohol is not

Cholesterol medication such as atorvastatin is routinely and wrongly stopped because of mildly raised liver enzymes; it is safe in fatty liver and reduces the heart disease that is the most common cause of death in this condition. Alcohol, by contrast, multiplies the damage from metabolic fat, and there is no protective amount once scarring is present. Sugar-sweetened drinks and fruit juice are the dietary factor most consistently tied to liver fat, while regular coffee is associated with less fibrosis. Our alcohol guide covers what counts as heavy drinking.

What else is checked once

A one-time screen for hepatitis B and C and for iron overload from hemochromatosis rules out causes that need different treatment, and hepatitis A and B vaccination protects a liver with less reserve. Sleep apnea and high triglycerides share the same insulin resistance and are treated alongside.

When it has become cirrhosis

Swelling of the legs or abdomen, yellowed eyes, vomiting blood, black stools, or new confusion means the liver is no longer keeping up and needs same-day care. Established cirrhosis brings liver cancer surveillance by ultrasound every six months and screening for enlarged veins in the esophagus. Our gastrointestinal team coordinates that surveillance with hepatology. The NIDDK and the American Liver Foundation publish patient guidance on diet, medication, and monitoring.

If you were told you have a fatty liver and nobody has calculated your scarring risk, schedule a visit; it takes one blood test.

Frequently Asked Questions

Yes, when it is caught before significant scarring. Losing about a tenth of body weight and keeping it off clears liver fat, settles inflammation, and can reverse early fibrosis, and liver enzymes usually return to normal within months. Once cirrhosis has developed the scarring is largely permanent, which is why the fibrosis score matters more than the fat itself.
Yes. Statins are safe in fatty liver, including with mildly raised liver enzymes, and they are important because heart disease, not liver failure, is the most common cause of death in people with this condition. Stopping a statin because of a fatty liver is a common mistake. Only decompensated cirrhosis changes that advice.
About five percent of body weight reduces liver fat, seven to ten percent resolves the inflammation of steatohepatitis in most people, and ten percent or more can improve scarring. For someone weighing 200 pounds that is roughly 20 pounds. How the weight comes off matters less than sustaining it, and GLP-1 medications reach that target for most people who stay on them.
A calculation from age, two liver enzymes, and platelet count that estimates how likely advanced scarring is. A low score means lifestyle treatment and a recheck in a few years; a higher score leads to a FibroScan or a hepatology referral. It is recommended for everyone with fatty liver, and for people with type 2 diabetes even when liver enzymes are normal.

Related Medications

Commonly prescribed medications for this condition

Getting Care in St. Petersburg

If you have questions about Fatty Liver Disease, a primary care team in St. Petersburg can evaluate your symptoms, order the right tests, coordinate any specialist care, and follow up with you over time.

Request an appointment